Corrigendum to "Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and meta-analysis" [J. Affect. Disord. 358C 2024, 432-439]
- PMID: 38815466
- PMCID: PMC12331248
- DOI: 10.1016/j.jad.2024.05.068
Corrigendum to "Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and meta-analysis" [J. Affect. Disord. 358C 2024, 432-439]
Figures
Erratum for
-
Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis.J Affect Disord. 2024 Aug 1;358:432-439. doi: 10.1016/j.jad.2024.05.037. Epub 2024 May 11. J Affect Disord. 2024. PMID: 38740269 Free PMC article.
References
-
- Rossini D, Magri L, Lucca A, Giordani S, Smeraldi E, Zanardi R, 2005. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. J Clin Psychiatry 66(12), 1569–1575. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
